Drugs / Fluzone HD trivalent
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2/3 | NCT06482359 Comparator | Feb → Nov 2025 | COVID-19, influenza | Novavax | Withdrawn | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Fluzone HD trivalent | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06482359 ↗ |
| Route | Intramuscular | “1 IM dose of Fluzone HD” NCT06482359 ↗ |